Drug intelligence / Profile preview

phenylalanine + tyrosine

Development stage
Unknown
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Phenylalanine + tyrosine is a combination of two essential amino acids, both of which serve as building blocks for protein synthesis and are precursors in the biosynthesis of catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine. Phenylalanine is converted in the body to tyrosine via the enzyme phenylalanine hydroxylase. Tyrosine then serves as a precursor for several important neurotransmitters and hormones. This combination may be used in nutritional supplementation or medical foods, particularly for individuals with specific metabolic needs (e.g., certain inherited disorders). The primary clinical context involves dietary management in conditions like phenylketonuria (PKU), where patients cannot metabolize phenylalanine efficiently and may require controlled intake of these amino acids[4][5][6][7]. There is also some evidence that combined supplementation can influence mental health parameters or cognitive performance under stress[1][3].

02

Targets

AMPAR (AMPA receptor)N-methyl-D-aspartate receptor glycine site (NMDAR glycine site)PAH (Phenylalanine hydroxylase)TH (Tyrosine hydroxylase)α2δ (Voltage-gated calcium channel alpha-2-delta subunit)PTC (50S ribosomal peptidyl transferase center)

Beyond the preview

Go deeper on phenylalanine + tyrosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phenylalanine + tyrosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call